Recent News
March 2014
Jan. 2014
Dec. 2013

VBI Vaccines is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. VBI’s innovative approach to vaccine development and growing pipeline of vaccine programs address significant market opportunities and are designed to answer critical unmet medical needs. VBI Vaccines’ eVLP platform allows the development of vaccine candidates with structures that mimic the target virus. Our thermostable LPV formulation technology allows the development of thermostable vaccines to ensure access to safe & effective vaccines for all.

Read more